Moreover, the reduced levels of both EDB-FN and SRp55 were associated with reduced invasive potential of the TGF-β-treated and drug-resistant MCF7 and MDA-MB-468 cells (Figure 5B,C), suggesting a direct or indirect role of EDB-FN in the altered invasive patterns of breast cancer cells. The gene discussed is FN1; the disease is breast cancer.